Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Schrodinger
SDGR
$1.38B
| $15.9M | ﹤0.01% |
443,484
+15,588
| +4% | +$452K |
|
1727
Mercury Systems
MRCY
$6.59B
| $15.9M | ﹤0.01% |
433,971
+23,586
| +6% | +$851K |
|
|
NTST
1728
NETSTREIT Corp
NTST
$2.09B
| $15.8M | ﹤0.01% |
886,995
+37,318
| +4% | +$585K |
|
1729
ACV Auctions
ACVA
$1.35B
| $15.8M | ﹤0.01% |
1,044,415
+18,626
| +2% | +$273K |
|
|
SASR
1730
DELISTED
Sandy Spring Bancorp Inc
SASR
| $15.8M | ﹤0.01% |
580,628
+40,374
| +7% | +$912K |
|
1731
Metallus
MTUS
$892M
| $15.8M | ﹤0.01% |
674,211
+30,317
| +5% | +$636K |
|
1732
DigitalOcean
DOCN
$15.6B
| $15.8M | ﹤0.01% |
430,894
-1,836
| -0.4% | -$50.8K |
|
1733
First Busey Corp
BUSE
$2.58B
| $15.8M | ﹤0.01% |
636,619
+31,442
| +5% | +$673K |
|
1734
First Bancorp
FBNC
$2.74B
| $15.8M | ﹤0.01% |
426,746
+26,149
| +7% | +$821K |
|
1735
NCR Voyix
VYX
$1.17B
| $15.8M | ﹤0.01% |
933,524
-595,204
| -39% | -$9.49M |
|
1736
Matthews International
MATW
$722M
| $15.8M | ﹤0.01% |
430,482
-6,991
| -2% | -$256K |
|
1737
Chewy
CHWY
$9.2B
| $15.8M | ﹤0.01% |
667,247
+39,301
| +6% | +$775K |
|
|
MRC
1738
DELISTED
MRC Global
MRC
| $15.8M | ﹤0.01% |
1,431,512
-9,650
| -0.7% | -$101K |
|
1739
Wolverine World Wide
WWW
$1.63B
| $15.8M | ﹤0.01% |
1,771,991
+103,368
| +6% | +$879K |
|
1740
Rocket Pharmaceuticals
RCKT
$367M
| $15.7M | ﹤0.01% |
525,452
+57,246
| +12% | +$1.26M |
|
1741
Cannae Holdings
CNNE
$675M
| $15.7M | ﹤0.01% |
805,332
+15,295
| +2% | +$279K |
|
1742
PC Connection
CNXN
$2.04B
| $15.7M | ﹤0.01% |
232,936
+3,812
| +2% | +$227K |
|
1743
Quanex
NX
$981M
| $15.6M | ﹤0.01% |
509,581
+9,172
| +2% | +$271K |
|
1744
Beam Therapeutics
BEAM
$2.74B
| $15.5M | ﹤0.01% |
571,236
+29,826
| +6% | +$741K |
|
1745
Pegasystems
PEGA
$5.51B
| $15.5M | ﹤0.01% |
635,780
-224
| -0% | -$5.24K |
|
1746
National Beverage
FIZZ
$2.93B
| $15.5M | ﹤0.01% |
311,371
+10,239
| +3% | +$490K |
|
|
RYZ
1747
Ryerson Holding Corp
RYZ
$1.5B
| $15.4M | ﹤0.01% |
444,476
+62,384
| +16% | +$1.86M |
|
1748
MasterBrand
MBC
$1.89B
| $15.4M | ﹤0.01% |
1,037,764
+12,464
| +1% | +$160K |
|
1749
Leonardo DRS
DRS
$11.9B
| $15.4M | ﹤0.01% |
768,420
+209,005
| +37% | +$3.94M |
|
1750
New Fortress Energy
NFE
$93M
| $15.4M | ﹤0.01% |
408,137
+16,172
| +4% | +$558K |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.